Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 847 results for "novartis ag"

Novartis India Q1 net up 3% at Rs 14.31 cr

Drug firm Novartis India today reported a 3.17% rise in its standalone net profit to Rs 14.31 crore for the quarter ended June 30, 2014. The company had posted a net profit of Rs 13.87 crore for the corresponding period of the previous fiscal, ... Business Standard India, 50 minutes ago
Novartis India Q1 net profit up 3% at Rs 14.31 crore Economic Times, 35 minutes ago

102 images for novartis ag, 1 week ago
4 Traders, 1 week ago
Miami Herald, 1 week ago
Time, 1 week ago
BusinessWeek, 1 week ago
BusinessWeek, 1 week ago
Boston Globe, 2 weeks ago
Deseret Morning News, 1 week ago
Value Walk, 1 week ago
TopNews United States, 1 week ago

Novartis AG (NVS) Trading Near $89.49 Resistance Level

Novartis AG ("NVS) presents a trading opportunity that offers a 3.28% return in just 177 days. A covered call on Novartis AG at the $87.50 level expiring on Jan. '15 offers an assigned return rate ...
 Individual.com13 hours ago Novartis AG (NVS) Showing Support Near $88.07  Individual.com3 days ago Novartis AG (NVS) Showing Bearish Technicals With Support At $88.72  Individual.com1 day ago Novartis AG (NVS) Showing Bullish Technicals With Resistance At $91.07  PredictWallStreet1 week ago

Amgen Nervous As FDA Paves Way For Novartis AG To Copy Drug Neupogen

FDA Accepts Sandoz Application For Biosimilar Filgrastim * Sandoz is the first company to announce it has filed for approval of a biologic under the biosimilars pathway created in the Biologics Price Competition and Innovation Act of 2009 ...
 BioSpace19 hours ago FDA Accepts Sandoz Application For Biosimilar Filgrastim - Quick Facts  RTTNews.com1 day ago GNW-News: FDA accepts Sandoz application for biosimilar filgrastim (english)  Pharmacy Choice19 hours ago NOVARTIS : FDA accepts Sandoz application for biosimilar filgrastim »  4 Traders1 day ago

Novartis AG (ADR) (NVS) Beats Analyst Estimates; Is Expected To Perform Well Backed By Recent Deals

In an interview with Bloomberg , Odile Rundquist, who is an analyst at Helvea, discusses on the second Qtr. results of the world's largest drug maker by revenue, Novartis AG (ADR) (NYSE: NVS ). I would say first that they do not really miss ...
 InsiderMonkey.com6 days ago More on Novartis Q2 results  Seeking Alpha1 week ago Novartis Q2 results by key product  Seeking Alpha1 week ago Novartis EPS in-line, misses on revenue  Seeking Alpha1 week ago

Potential Novartis AG (NVS) Trade Has 3.50% Downside Protection

The patented option-trade picking algorithms that power's Artificial Intelligence Center Aare highlighting two trades on Novartis AG ("NVS) today after it closed at ...
 Individual.com2 days ago

Novartis Q2 net income increases

(MarketLine via COMTEX News Network) -- Novartis AG has reported that total net income attributable to shareholders for the second quarter ended June 30, 2014 was $2.55 billion, or $1.03 per diluted share, compared to $2.52 billion, or $1.01 per ...
 PredictWallStreet2 days ago Novartis net up by 3% to $3,283 million in Q2  PharmaBiz6 days ago Novartis AG reaffirms FY 2014 outlook - Conference Call  Reuters UK1 week ago Novartis Q2 Profit Up; Backs FY View - Quick Facts  RTTNews.com1 week ago

Novartis cites momentum in 3 per cent profit rise

Swiss pharmaceutical company Novartis AG posted a 3 per cent rise in second-quarter profits today, reflecting what it described as solid growth and an increased focus on core products. Profits during the April-June quarter rose to USD 3.28 billion, ...
 Business Standard1 week ago Novartis Q2 Profit Rises; Backs Full-year Outlook  RTTNews.com1 week ago Novartis Cites Momentum in 3 Percent Profit Rise  ABC News1 week ago Pharmaceutical company Novartis AG cites momentum in 3 profit increase  Big News Network1 week ago
Bidness Etc

Novartis Sees Lower-Than-Expected Profits

Novartis's sales and profits for its second quarter fall below the Street's expectations for 2QFY14 Sign up for Daily Newsletter Sign Up Click Ticker to See live coverage Novartis AG (NVS) announced its financial and operational results for ...
 Bidness Etc1 week ago Novartis Profit Lifted by Emerging Markets  Austin American Statesman1 week ago Novartis Profit Misses Estimates; Forecast Confirmed  Bloomberg1 week ago Novartis Expects major part of Revenue from New Products  TopNews United States1 week ago

Novartis and Google To Develop 'Smart' Contact Lens

Pharmaceutical giant Novartis International AG and technology giant Google have teamed up to create a smart contact lens capable of measuring diabetics' glucose levels and correcting farsightedness. As part of the deal, Novartis is licensing ...
 Sci-Tech Today6 days ago Novartis, Google Team for Smart Lens  Sci-Tech Today1 week ago Google, Novartis partner to make smart contact lens  Techcircle.in1 week ago Google Signs Controversial Deal With Pharmaceutical Giant Novartis  DailyTech1 week ago

Hopp compra a Novartis y BWK acciones en LTS

ANDERNACH, Alemania, 17 de julio de 2014 /PRNewswire/ -- La junta de supervisión ("Aufsichtsrat") y la junta directiva ("Vorstand") de LTS han finalizado la evaluación de opciones estratégicas para el desarrollo futuro del grupo LTS. LTS ...
 PR Newswire1 week ago Hopp adquire ações LTS da Novartis e da BWK  PR Newswire1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less